Yu-Xian Bai
Overview
Explore the profile of Yu-Xian Bai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang F, Liu T, Yuan X, Luo H, Gu K, Yuan Y, et al.
Am J Cancer Res
. 2020 Oct;
10(9):3037-3046.
PMID: 33042632
Gastric cancer (GC) is the second most common cancer in China. The ToGA study showed that trastuzumab in combination with fluoropyrimidine plus cisplatin prolonged overall survival (OS) in patients with...
2.
Zhu J, Zhu W, Hu J, Yang W, Liu P, Liu Q, et al.
Ultrasound Med Biol
. 2020 Jun;
46(8):2030-2043.
PMID: 32475714
Sono-photodynamic therapy (SPDT) activates the same photo-/sonosensitizer and exerts more marked antitumor effects than sonodynamic therapy or photodynamic therapy. We aimed to explore the utilization of curcumin (CUR)-loaded poly(L-lactide-co-glycolide) microbubble...
3.
Xu R, Shen L, Wang K, Wu G, Shi C, Ding K, et al.
Chin J Cancer
. 2017 Dec;
36(1):97.
PMID: 29273089
Background: Metastatic colorectal cancer (mCRC) patients with progressive disease after all available standard therapies need new medication for further treatment. Famitinib is a small-molecule multikinase inhibitor, with promising anticancer activities....
4.
Yang L, Sun X, Qin S, Chen Y, Zhang H, Cheng Y, et al.
Chin Clin Oncol
. 2017 Jan;
5(6):79.
PMID: 28061543
Background: The granisetron transdermal delivery system (GTDS) has been demonstrated effectiveness in the control of chemotherapy-induced nausea and vomiting (CINV) in previous studies. This is the first phase III study...
5.
Liu K, Guan Z, Liang Y, Yang X, Peng J, Huang H, et al.
Arch Med Sci
. 2014 Oct;
10(4):717-24.
PMID: 25276156
Introduction: The aim of this study was to compare the efficacy and toxicity of dicycloplatin plus paclitaxel with those of carboplatin plus paclitaxel as first-line treatment for patients with advanced...
6.
Han Y, Yang Y, Yuan H, Zhang T, Sui H, Wei X, et al.
Pathology
. 2014 Jul;
46(5):396-401.
PMID: 24977734
Colorectal cancer (CRC) is one of the most common cancers worldwide. Long non-coding RNAs (lncRNAs) have been shown to play important regulatory roles in cancer biology, and functional lncRNAs can...
7.
Deng T, Zhang L, Liu X, Xu J, Bai Y, Wang Y, et al.
Med Oncol
. 2013 Nov;
30(4):752.
PMID: 24174316
Poor prognosis is associated with patients with metastatic colorectal cancer. To seek effective methods, we examine the efficacy and safety of bevacizumab plus FOLFIRI as a second-line chemotherapy in Chinese...
8.
Liu L, Bai Y, Zhou J, Sun X, Sui H, Zhang W, et al.
Int J Mol Sci
. 2013 Sep;
14(9):18973-88.
PMID: 24065098
Estrogen-related genes and the fat mass and obesity-associated (FTO) gene play a critical role in estrogen metabolism, and those polymorphisms are associated with a poor prognosis in breast cancer. However,...
9.
Ohtsu A, Ajani J, Bai Y, Bang Y, Chung H, Pan H, et al.
J Clin Oncol
. 2013 Sep;
31(31):3935-43.
PMID: 24043745
Purpose: The oral mammalian target of rapamycin inhibitor everolimus demonstrated promising efficacy in a phase II study of pretreated advanced gastric cancer. This international, double-blind, phase III study compared everolimus...
10.
Du X, Li Y, Wu C, Zhou J, Han Y, Sui H, et al.
Biomed Pharmacother
. 2013 Apr;
67(5):417-24.
PMID: 23582790
Dihydroartemisinin (DHA) has recently been shown anti-tumor activity in various cancer cells. However, its effect on esophageal cancer remains unclear. In this study, for the first time, we demonstrated that...